Aztech Sciences Competitors and Similar CompaniesClear all
CanSino Biologics's competitors and similar companies include FibroGen.
 CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | |
Founding Date | Founding Date 2009 | Founding Date 1993 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tianjin, CN HQ | Locations San Francisco, US HQ |
Employees | Employees 1,10526% decrease | Employees 53115% increase |
Financial | ||
Revenue (est.) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $6.4m (FY, 2025) |
Cost of goods | Cost of goods ¥81.4m (FY, 2025) | Cost of goods $556k (FY, 2025) |
Gross profit | Gross profit ¥1.1b (FY, 2025) | Gross profit $5.9m (FY, 2025) |
Net income | Net income ¥27.9m (FY, 2025) | Net income $183.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
FibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company